Neuphoria Therapeutics Inc.

NEUP·NasdaqGM
Compare
3.3200−0.0400 (−1.19%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3.3600
Open3.3200
Day range3.32003.3800
52-week range3.190018.3900
Off day high−1.78%
Off 52-week high−81.95%
Volume9.92K
Avg. volume (3M)161.55K
Market cap17.97M
EPS (TTM)-3.06
Forward P/E-1.35
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding5.41M
Short interest—
Earnings dateMar 13, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
NEUP NMRA ABVC ALZN SILO VTGN
Market cap 17.97M 82.17M 26.16M 6.32M 3.06M 10.06M
P/E (TTM) — — — — — —
Forward P/E -1.3 -0.7 -2.2 -1.5 -2.1 -0.1
Price/book 0.6 1.8 2.4 1.1 0.3 0.4
Dividend yield — — — — — —
1-year change −79.90% −74.41% −67.11% −41.52% −84.39% −93.86%
Today −1.19% −8.07% −2.02% −2.25% +1.36% −4.02%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All NEUP news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.